How do we use therapeutic drug monitoring to improve outcomes from severe infections in critically ill patients?

Abstract

High mortality and morbidity rates associated with severe infections in the critically ill continue to be a significant issue for the healthcare system. In view of the diverse and unique pharmacokinetic profile of drugs in this patient population, there is increasing use of therapeutic drug monitoring (TDM) in attempt to optimize the exposure of antibiotics… (More)
DOI: 10.1186/1471-2334-14-288

Topics

3 Figures and Tables

Blog articles referencing this paper

Slides referencing similar topics